|
Press
release n° 40 - 12 May 2003
IFAH* elects new President and outlines
strategic objectives for 2003/4
Brussels 12
May 2003
At its 13th General Assembly, the International
Federation for Animal Health (IFAH) has both announced
its ongoing strategic objectives, and elected a new
President to oversee their achievement.
Patrick James, President of Elanco Animal Health,
succeeds Alan Reade, Executive Chairman of Merial
Limited, to the IFAH Presidency. As President, James
will continue to enhance and develop IFAH’s momentum, as
it continues successfully to connect and represent the
animal health industry over five continents.
As outgoing President, Reade not only reported on
achievements and activities in the immediate past year,
2002, but outlined IFAH’s current and future strategies.
He was delighted, he said, to report the considerable
achievements of IFAH in its first year as an integrated
federation, particularly noteworthy being the successful
integration of one of the industry’s key regions –
Europe – into the broader organisation. This led in
January 2003 to the creation of IFAH-Europe as a
distinct division within IFAH.
For 2003 Reade announced that the
IFAH Board had identified three strategic priorities.
They were he said, regulatory affairs, comprising the
vital elements of harmonisation, antimicrobial
availability, the precautionary principle and regulatory
process efficiency; the food chain with emphasis on the
need for communication and relationship building with
key stakeholders; and image management based on the need
for the industry to be understood and recognised for its
contribution to society at large.
IFAH’s aim Reade emphasised was “to
ensure that the animal health industry achieves the most
appropriate platforms from which to articulate its
position, and from which to develop its activities and
expand understanding about its role.”
Taking up the mantle as IFAH’s newly
elected President, James continued and expanded his
predecessors’ theme. “ It is our intention,” he said “to
work through IFAH to ensure that our industry’s position
on a number of significant issues is fully appreciated
and understood. We want to participate fully in debates
which we may not start, but which profoundly affect us,
and we want a wide variety of stakeholders, including
the general public, to know the contribution we make on
a daily basis to people’s lives.”
At the same time James announced the
election of the other members of the IFAH Executive
Committee: Friedrich Berschauer (Bayer), Pedro
Lichtinger (Pfizer), Alan Reade (Merial), Ruurd Stolp (Intervet),
and Eric Marée (Virbac) as Treasurer. All CEO’s of their
companies and elected from the IFAH Board members, they
will form IFAH’s Executive Committee and be responsible
for supporting James achieve IFAH’s objectives.
“I am looking forward to working with
my industry colleagues to ensure its effective
international representation,” concluded James.
Ends
IFAH, the International Federation
for Animal Health is a not for profit international
organisation registered under Belgian law. For further
information on IFAH, including a list of members, please
visit www.ifahsec.org
For further press information please
contact Jean-Louis Delforge, IFAH Executive Director
IFAH
Rue Defacqz, 1
B-1000 Brussels
Tel.: +32 (0)2 541 0111
Fax : +32 (0)2 541 0119
E-mail :
ifah@ifahsec.org
* IFAH, the International Federation for Animal Health,
is the federation representing manufacturers of
veterinary medicines, vaccines and other animal health
products in both developed and developing countries
across five continents
|